Identification of a common variant in the TFR2 gene implicated in the physiological regulation of serum iron levels.
暂无分享,去创建一个
Toshiko Tanaka | S. Bandinelli | D. Hernandez | L. Ferrucci | D. Schlessinger | E. Schadt | D. Longo | J. Guralnik | M. Uda | S. Sanna | A. Maschio | F. Busonero | A. Hicks | P. Pramstaller | I. Pichler | E. Porcu | C. Pattaro | C. Schwienbacher | C. Minelli | S. Naitza | F. Marroni | D. Witcher | V. Wroblewski | G. Weiss | I. Theurl | A. Zanon | Carsten Gnewuch | A. Murphy | E. Aigner | M. Mitterer | S. Melville | Maria Grazia Piras | C. Gnewuch | Toshiko Tanaka | Scott A. Melville
[1] Matthias W. Hentze,et al. Two to Tango: Regulation of Mammalian Iron Metabolism , 2010, Cell.
[2] S. Bandinelli,et al. Proinflammatory state, hepcidin, and anemia in older persons. , 2010, Blood.
[3] Xia Yang,et al. Liver and Adipose Expression Associated SNPs Are Enriched for Association to Type 2 Diabetes , 2010, PLoS genetics.
[4] A. Ikai,et al. Characterization of the interaction between diferric transferrin and transferrin receptor 2 by functional assays and atomic force microscopy. , 2010, Journal of molecular biology.
[5] Toshiko Tanaka,et al. A genome-wide association analysis of serum iron concentrations. , 2010, Blood.
[6] G. Weiss. Genetic mechanisms and modifying factors in hereditary hemochromatosis , 2010, Nature Reviews Gastroenterology &Hepatology.
[7] Christian Gieger,et al. A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium , 2009, Nature Genetics.
[8] Gonçalo Abecasis,et al. Genome-wide association study identifies variants in TMPRSS6 associated with hemoglobin levels , 2009, Nature Genetics.
[9] Ian H. Frazer,et al. Common variants in TMPRSS6 are associated with iron status and erythrocyte volume , 2009, Nature Genetics.
[10] Christian Gieger,et al. Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium , 2009, Nature Genetics.
[11] Gloria Velasco,et al. Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis , 2009, Haematologica.
[12] C. Datz,et al. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. , 2009, Blood.
[13] Leena Peltonen,et al. Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels. , 2009, American journal of human genetics.
[14] M. Muckenthaler,et al. Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis. , 2009, Journal of Alzheimer's disease : JAD.
[15] G. Abecasis,et al. Genotype imputation. , 2009, Annual review of genomics and human genetics.
[16] Jerry Kaplan,et al. The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. , 2008, Cell metabolism.
[17] D. Girelli,et al. Immunoassay for human serum hepcidin. , 2008, Blood.
[18] M. Cazzola,et al. A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron , 2008, Haematologica.
[19] C. López-Otín,et al. Membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis. , 2008, Blood.
[20] D. Schwartz,et al. The role of correction of anaemia in patients with congestive heart failure: A short review , 2008, European journal of heart failure.
[21] D. Girelli,et al. Advances in Quantitative Hepcidin Measurements by Time-of-Flight Mass Spectrometry , 2008, PloS one.
[22] M. Muckenthaler. Fine tuning of hepcidin expression by positive and negative regulators. , 2008, Cell metabolism.
[23] Ramaiah Nagaraja,et al. Phosphodiesterase 8B gene variants are associated with serum TSH levels and thyroid function. , 2008, American journal of human genetics.
[24] B. Beutler,et al. The Serine Protease TMPRSS6 Is Required to Sense Iron Deficiency , 2008, Science.
[25] N. Andrews,et al. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA) , 2008, Nature Genetics.
[26] Thomas J. Hudson,et al. Differential Allelic Expression in the Human Genome: A Robust Approach To Identify Genetic and Epigenetic Cis-Acting Mechanisms Regulating Gene Expression , 2008, PLoS genetics.
[27] V. Felitti,et al. Screening for hemochromatosis by measuring ferritin levels: a more effective approach. , 2007, Blood.
[28] Jerry Kaplan,et al. Regulation of iron acquisition and storage: consequences for iron-linked disorders , 2008, Nature Reviews Molecular Cell Biology.
[29] M. Devoto,et al. Estimates of Genetic and Environmental Contribution to 43 Quantitative Traits Support Sharing of a Homogeneous Environment in an Isolated Population from South Tyrol, Italy , 2007, Human Heredity.
[30] W. Fawzi,et al. Iron status is an important cause of anemia in HIV-infected Tanzanian women but is not related to accelerated HIV disease progression. , 2007, The Journal of nutrition.
[31] N. Andrews,et al. Iron homeostasis. , 2007, Annual review of physiology.
[32] Thomas Meitinger,et al. The genetic study of three population microisolates in South Tyrol (MICROS): study design and epidemiological perspectives , 2007, BMC Medical Genetics.
[33] C. V. van Duijn,et al. Heritability of Serum Iron, Ferritin and Transferrin Saturation in a Genetically Isolated Population, the Erasmus Rucphen Family (ERF) Study , 2006, Human Heredity.
[34] G. Abecasis,et al. Heritability of Cardiovascular and Personality Traits in 6,148 Sardinians , 2006, PLoS genetics.
[35] V. Subramaniam,et al. First phenotypic description of transferrin receptor 2 knockout mouse, and the role of hepcidin , 2005, Gut.
[36] Jerry Kaplan,et al. Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization , 2004, Science.
[37] Paige S. Davies,et al. Expression of the Hereditary Hemochromatosis Protein HFE Increases Ferritin Levels by Inhibiting Iron Export in HT29 Cells* , 2004, Journal of Biological Chemistry.
[38] M. Hentze,et al. Balancing Acts Molecular Control of Mammalian Iron Metabolism , 2004, Cell.
[39] J. Manson,et al. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. , 2004, JAMA.
[40] G. Novelli,et al. Molecular analysis using DHPLC of cystic fibrosis: increase of the mutation detection rate among the affected population in Central Italy , 2004, BMC Medical Genetics.
[41] M. Cazzola,et al. Differential HFE allele expression in hemochromatosis heterozygotes. , 2001, Gastroenterology.
[42] Luigi Ferrucci,et al. Subsystems Contributing to the Decline in Ability to Walk: Bridging the Gap Between Epidemiology and Geriatric Practice in the InCHIANTI Study , 2000, Journal of the American Geriatrics Society.
[43] G. Béréziat,et al. Differential HFE allele expression in hemochromatosis heterozygotes. , 2000, Gastroenterology.
[44] Paolo Gasparini,et al. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22 , 2000, Nature Genetics.
[45] D. Duffy,et al. Effects of HFE C282Y and H63D polymorphisms and polygenic background on iron stores in a large community sample of twins. , 2000, American journal of human genetics.
[46] W. Sly,et al. Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[47] H. Koeffler,et al. Molecular Cloning of Transferrin Receptor 2 , 1999, The Journal of Biological Chemistry.
[48] M. C. Ellis,et al. A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis , 1996, Nature Genetics.
[49] I. Rossman,et al. Normal Human Aging: The Baltimore Longitudinal Study of Aging , 1986 .
[50] David Arenberg,et al. Normal Human Aging: The Baltimore Longitudinal Study on Aging , 1984 .